about
Low frequency of NS5A relevant resistance-associated substitutions to Elbasvir among hepatitis C virus genotype 1a in Spain: a cross-sectional study.Relationship between European mitochondrial haplogroups and chronic renal allograft rejection in patients with kidney transplant.Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis.FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients.PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional studyrs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysisAssociation between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional studySoluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of OutcomeImpact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit.NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in SpainRelationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patientsMx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study.IL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective study.Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.IL7RA polymorphisms are not associated with AIDS progression.Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patients.Short Communication: CXCL12 rs1029153 Polymorphism Is Associated with the Sustained Virological Response in HIV/Hepatitis C Virus-Coinfected Patients on Hepatitis C Virus Therapy.Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.IL-1B rs16944 polymorphism is related to septic shock and death.Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients.IL15 polymorphism is associated with advanced fibrosis, inflammation-related biomarkers and virological response in human immunodeficiency virus/hepatitis C virus coinfection.Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients.IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART.TLR3 polymorphisms are associated with virologic response to hepatitis C virus (HCV) treatment in HIV/HCV coinfected patients.Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients.Transcriptomic correlates of organ failure extent in sepsis.Association between IL7RA polymorphisms and the successful therapy against HCV in HIV/HCV-coinfected patients.CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV/HCV-coinfected patients.ADAR1 polymorphisms are related to severity of liver fibrosis in HIV/HCV-coinfected patients.PPARγ2 Pro12Ala polymorphism is associated with sustained virological response in HIV/HCV-coinfected patients under HCV therapy.Mitochondrial DNA haplogroups are associated with severe sepsis and mortality in patients who underwent major surgery.European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients.SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients.Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients.IL28RA polymorphism (rs10903035) is associated with insulin resistance in HIV/HCV-coinfected patients.HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy.IL28B polymorphisms are associated with severity of liver disease in human immunodeficiency virus (HIV) patients coinfected with hepatitis C virus.Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.
P50
Q33767618-4C936F76-CDF2-4825-BFC6-47D7CEFC6B91Q34102044-0F3DEFBE-4F8B-468B-B552-C23D2892C6FDQ34250648-5E2F1888-BB1C-42C1-A600-E5B7D2E73A38Q34474404-1942F187-CA29-4E3C-BC56-419672532002Q34803775-46B602B1-97CE-41FD-9955-0D840031F84FQ35142495-6B611752-9535-46C3-ADF0-BDB871AF0C45Q35197174-C25CDDDF-A300-47C3-A8EF-6077DF1C71E2Q35799774-E6188F30-8C83-4B25-AF16-FE57B0FA54C8Q35803583-C8C63AA3-3435-45C3-8D6B-3282608D8923Q35916020-0AD023B7-6F17-4E81-A107-6633EFC967C9Q35958590-5C530914-0B4C-43F3-802B-77DBA081A00EQ36148440-44F29240-EF77-4153-A2B4-1F755DE5323DQ37230823-AEC32E01-F991-47C6-A51E-20B4B9FB8E25Q37615221-8B5AEB21-C028-42C1-8B6A-4A1489B9193CQ37672359-A3C31183-7065-44CD-9EEA-2BD629EECA8DQ40053800-C08A06A8-5DC5-443C-854A-5D22A1B36B6FQ40087851-4FEEED13-2F61-47AB-B249-DFB845B67539Q40092302-02776B54-E985-46E0-8D0F-6D384406325DQ40394994-556EA2F4-90B7-44FB-BE06-C6A5700791F2Q40444355-BA04AEED-2AA1-492A-9BD2-A40CC06D7801Q40446613-D7F053FD-9C1C-45C7-B521-D746D025EEBDQ40734101-C51B5152-0F72-46C8-B62A-9D931509246BQ40808386-DD7EB952-FBED-4845-A2F7-F790FD08E96DQ40835342-84B5434A-C646-4ACD-8501-3AF496067736Q40984077-BC079BD4-69CD-49BB-B367-D7260838AA71Q41433750-F401ADF9-FF93-4F42-A48A-74BB7212BE58Q41563436-45226EC4-363D-415E-9514-6925530BA3D3Q41564476-3E319CEE-174A-4567-B71C-C6850D798C25Q41733689-F224F1F7-F56F-4F60-BA44-49A335577709Q41740644-F369D3E7-26B3-4DFA-99E5-717AAFCCA46DQ41919708-8D14DDF5-BB30-4443-866E-F0689855FFC5Q42203170-95A0A21F-5AB4-44D6-B3A9-AE1E921A4E63Q42204961-843AB76E-D2D5-4FC6-99B6-C4F96EFD808CQ42234661-8C893D55-F740-4E92-9B00-424B8CEB4D78Q42238889-2DE476F9-7920-461B-8232-72CBBD7A9102Q42242015-3370C002-2784-42E5-9419-10518F2610BAQ42242609-F9E796CA-B8BA-425D-AA3A-B9B7F602F19BQ42287097-1BD5A76D-8B65-450D-9F5D-9E2CCC24EB72Q42985569-64D64D3A-539B-4EFF-A4B9-C32CC889F826Q42985931-78D84041-EE9B-491C-87B5-49B32499C468
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
María Ángeles Jiménez-Sousa
@ast
María Ángeles Jiménez-Sousa
@en
María Ángeles Jiménez-Sousa
@es
María Ángeles Jiménez-Sousa
@nl
type
label
María Ángeles Jiménez-Sousa
@ast
María Ángeles Jiménez-Sousa
@en
María Ángeles Jiménez-Sousa
@es
María Ángeles Jiménez-Sousa
@nl
prefLabel
María Ángeles Jiménez-Sousa
@ast
María Ángeles Jiménez-Sousa
@en
María Ángeles Jiménez-Sousa
@es
María Ángeles Jiménez-Sousa
@nl
P1053
I-8725-2012
P106
P1153
36668651000
P21
P31
P3829
P496
0000-0002-1945-6169